Preoperative axillary ultrasonography alone is insufficient to safely exclude sentinel lymph node metastasis in breast cancer patients receiving neoadjuvant chemotherapy, particularly in luminal A and luminal B/HER2-negative subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.